Tobias Madl

Prof. Dr. Tobias Madl

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2010 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
TGThomas Güttler
Thomas Güttler
TMTobias Madl
Tobias Madl
PNPiotr Neumann
Piotr Neumann
DDDanilo Deichsel
Danilo Deichsel
LCLorenzo Corsini
Lorenzo Corsini
DGDirk Görlich
Dirk Görlich

1 February 2014 in Cell
Verified
Journal Article
Closed access
EKElif Karagöz
Elif Karagöz
ADAfonso M.S. Duarte
Afonso M.S. Duarte
EAElias Akoury
Elias Akoury
HIHans Ippel
Hans Ippel
JBJacek Biernat
Jacek Biernat
SRStefan G.D. Rüdiger
Stefan G.D. Rüdiger

11 September 2012 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
DDDorothee Dormann
Dorothee Dormann
TMTobias Madl
Tobias Madl
CVChiara F Valori
Chiara F Valori
EBEva Bentmann
Eva Bentmann
STSabina Tahirovic
Sabina Tahirovic
CHChristian Haass
Christian Haass
Fused in sarcoma (FUS) is a nuclear protein that carries a proline‐tyrosine nuclear localization signal (PY‐NLS) and is imported into the nucleus via Transportin (TRN). Defects in nuclear import of FUS have been implicated in neurodegeneration, since mutations in the PY‐NLS of FUS cause amyotrophic lateral sclerosis (ALS). Moreover, FUS is deposited in the cytosol in a subset of frontotemporal lobar degeneration (FTLD) patients. Here, we show that arginine methylation modulates nuclear import of FUS via a novel TRN‐binding epitope. Chemical or genetic inhibition of arginine methylation restores TRN‐mediated nuclear import of ALS‐associated FUS mutants. The unmethylated arginine–glycine–glycine domain preceding the PY‐NLS interacts with TRN and arginine methylation in this domain reduces TRN binding. Inclusions in ALS‐FUS patients contain methylated FUS, while inclusions in FTLD‐FUS patients are not methylated. Together with recent findings that FUS co‐aggregates with two related proteins of the FET family and TRN in FTLD‐FUS but not in ALS‐FUS, our study provides evidence that these two diseases may be initiated by distinct pathomechanisms and implicates alterations in arginine methylation in pathogenesis. There is a [Have you seen?][1] (November 2012) associated with this Article. [1]: http://dx.doi.org/10.1038/emboj.2012.291

13 July 2011 in Nature
Verified
Journal Article
Closed access
PDF file
CMCameron Mackereth
Cameron Mackereth
TMTobias Madl
Tobias Madl
SBSophie Bonnal
Sophie Bonnal
BSBernd Simon
Bernd Simon
KZKatia Zanier
Katia Zanier
MSMichael Sattler
Michael Sattler

1 April 2021 in Cell Reports
Verified
Journal Article
Open access
SSSabrina Schroeder
Sabrina Schroeder
SHSebastian J. Hofer
Sebastian J. Hofer
AZAndreas Zimmermann
Andreas Zimmermann
RPRaimund Pechlaner
Raimund Pechlaner
CDChristopher Dammbrueck
Christopher Dammbrueck
FMFrank Madeo
Frank Madeo
Decreased cognitive performance is a hallmark of brain aging, but the underlying mechanisms and potential therapeutic avenues remain poorly understood. Recent studies have revealed health-protective and lifespan-extending effects of dietary spermidine, a natural autophagy-promoting polyamine. Here, we show that dietary spermidine passes the blood-brain barrier in mice and increases hippocampal eIF5A hypusination and mitochondrial function. Spermidine feeding in aged mice affects behavior in homecage environment tasks, improves spatial learning, and increases hippocampal respiratory competence. In a Drosophila aging model, spermidine boosts mitochondrial respiratory capacity, an effect that requires the autophagy regulator Atg7 and the mitophagy mediators Parkin and Pink1. Neuron-specific Pink1 knockdown abolishes spermidine-induced improvement of olfactory associative learning. This suggests that the maintenance of mitochondrial and autophagic function is essential for enhanced cognition by spermidine feeding. Finally, we show large-scale prospective data linking higher dietary spermidine intake with a reduced risk for cognitive impairment in humans.

20 November 2011 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
KTKonstantinos Tripsianes
Konstantinos Tripsianes
TMTobias Madl
Tobias Madl
MMMartin Machyna
Martin Machyna
DFDimitrios Fessas
Dimitrios Fessas
CEClemens Englbrecht
Clemens Englbrecht
MSMichael Sattler
Michael Sattler